Alpha 2.0
Login Register
» Articles » PMID: 21412066

Is Lower Serum 25-hydroxy Vitamin D Associated with Efavirenz or the Non-nucleoside Reverse Transcriptase Inhibitor Class?

Overview
Journal AIDS
Specialty Infectious Diseases
Date 2011 Mar 18
PMID 21412066
Citations 4
Authors
Christoph A Fux
Sandra Baumann
Hansjakob Furrer
Nicolas J Mueller
Affiliations
Soon will be listed here.
Citing Articles

Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.

Nylen H, Habtewold A, Makonnen E, Yimer G, Bertilsson L, Burhenne J Medicine (Baltimore). 2016; 95(34):e4631.

PMID: 27559961 PMC: 5400328. DOI: 10.1097/MD.0000000000004631.

Recommendations for evaluation and management of bone disease in HIV.

Brown T, Hoy J, Borderi M, Guaraldi G, Renjifo B, Vescini F Clin Infect Dis. 2015; 60(8):1242-51.

PMID: 25609682 PMC: 4400413. DOI: 10.1093/cid/civ010.

Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study.

Branch A, Barin B, Rahman A, Stock P, Schiano T Liver Transpl. 2013; 20(2):156-64.

PMID: 24338934 PMC: 3946843. DOI: 10.1002/lt.23784.

Protease inhibitor monotherapy: what is its role?.

Estebanez M, Arribas J Curr HIV/AIDS Rep. 2012; 9(2):179-85.

PMID: 22362299 DOI: 10.1007/s11904-012-0112-1.